Involvement of multidrug resistance-associated protein 2 (ABCC2/Mrp2) in biliary excretion of micafungin in rats

被引:11
|
作者
Abe, Fumie [1 ]
Ueyama, Jun [2 ]
Kimata, Akiko [2 ]
Kato, Miki [1 ]
Hayashi, Tamon [1 ]
Nadai, Masayuki [3 ]
Saito, Hiroko [1 ]
Takeyama, Naoshi [4 ]
Noguchi, Hiroshi [4 ]
Hasegawa, Takaaki [1 ]
机构
[1] Aichi Med Univ, Dept Pharm & Pharmacokinet, Sch Med, Nagakute, Aichi 4801195, Japan
[2] Nagoya Univ, Dept Med Technol, Sch Hlth Sci, Higashi Ku, Nagoya, Aichi 4618673, Japan
[3] Meijo Univ, Fac Pharmaceut Sci, Tenpaku Ku, Nagoya, Aichi 4688503, Japan
[4] Aichi Med Univ, Dept Crit Care Med, Sch Med, Nagakute, Aichi 4801195, Japan
关键词
micafungin; multidrug resistance-associated protein 2 (ABCC2/Mrp2) hepatobiliary excretion; Eisai hyperbilirubinemic rats (EHBR);
D O I
10.1016/j.lfs.2008.06.013
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The drug transporter, multidrug resistance-associated protein 2 (ABCC2/Mrp2), is known to play important roles in excretion of various drugs. In the present study, we investigated whether Mrp2 is involved in the transport of micafungin, a newly developed antifungal agent. When Sprague-Dawley rats received an intravenous injection of micafungin (1 mg/kg) in combination with cyclosporine, the cyclosporine significantly delayed the disappearance of micafungin from plasma and decreased the systemic clearance and volume of distribution at steady-state of micafungin to 54% and 65% of the corresponding control values, respectively. When Sprague-Dawley rats received a constant-rate infusion of micafungin, cyclosporine significantly decreased the steady-state biliary clearance of micafungin (similar to 80%). A significant decrease in the biliary clearance of micafungin (similar to 60%) was observed in Eisai hyperbilirubinemic rats, which have a hereditary deficiency in Mrp2. The present findings at least suggest that Mrp2 is involved mainly in the hepatobiliary excretion of micafungin in rats. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:229 / 235
页数:7
相关论文
共 50 条
  • [41] Kinetic characterization of ribozymes directed against the cisplatin resistance-associated ABC transporter cMOAT/MRP2/ABCC2
    Materna, V
    Holm, PS
    Dietel, M
    Lage, H
    CANCER GENE THERAPY, 2001, 8 (03) : 176 - 184
  • [42] Biliary excretion of 5 (and 6)-carboxy-2′,7′-dichlorofluorescein (CDF) by multidrug resistance-associated protein 2 (Mrp2) in rat hepatocyte cultures
    Ellis, Lucy C. J.
    Weaver, Richard J.
    Hawksworth, Gabrielle M.
    TOXICOLOGY, 2007, 240 (03) : 174 - 174
  • [43] Characterization of As(GS)3 and [(GS)2AsSe]-transport by the human multidrug resistance protein 2 (MRP2/ABCC2)
    Carew, Michael Wayne
    Leslie, Elaine MacKay
    FASEB JOURNAL, 2009, 23
  • [44] Characterization of As(GS)3 and [(GS)2AsSe]- transport by the human multidrug resistance protein 2 (MRP2/ABCC2)
    Carew, Michael Wayne
    Leslie, Elaine MacKay
    FASEB JOURNAL, 2009, 23
  • [45] Involvement of the drug transporters P glycoprotein and multidrug resistance-associated protein Mrp2 in telithromycin transport
    Yamaguchi, S
    Zhao, YL
    Nadai, M
    Yoshizumi, H
    Cen, XB
    Torita, S
    Takagi, K
    Takagi, K
    Hasegawa, T
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (01) : 80 - 87
  • [46] Differential involvement of Mrp2 (Abcc2) and Bcrp (Abcg2) in biliary excretion of 4-methylumbelliferyl glucuronide and sulfate in the rat
    Zamek-Gliszczynski, Maciej J.
    Hoffmaster, Keith A.
    Humphreys, Joan E.
    Tian, Xianbin
    Nezasa, Ken-ichi
    Brouwer, Kim L. R.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 319 (01): : 459 - 467
  • [47] Genetic variation and haplotype structure of human multidrug resistance-associated protein 2 (MRP2).
    Nguyen, TD
    Huang, CC
    Kawamoto, M
    Carlson, EJ
    Herskowitz, I
    Giacomini, KM
    Kroetz, DL
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (02) : P59 - P59
  • [48] Induction of hepatic and intestinal multidrug resistance-associated protein 2 (Mrp2) by spironolactone (SL)
    Catania, VA
    Luquita, MG
    Pozzi, EJS
    Pellegrino, JM
    Ochoa, JE
    Mottino, AD
    JOURNAL OF HEPATOLOGY, 2002, 36 : 251 - 251
  • [49] Effects of poloxamer 407-induced hyperlipidemia on hepatic multidrug resistance protein 2 (Mrp2/Abcc2) and the pharmacokinetics of mycophenolic acid in rats
    Kwon, Mi Hye
    Yoon, Ji Na
    Baek, Yu Jin
    Kim, Yu Chul
    Cho, Yong Yeon
    Kang, Hee Eun
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2016, 37 (06) : 352 - 365
  • [50] Functional analysis of nonsynonymous single nucleotide polymorphisms of multidrug resistance-associated protein 2 (ABCC2)
    Megaraj, Vandana
    Zhao, Tianyong
    Paumi, Christian M.
    Gerk, Phillip M.
    Kim, Richard B.
    Vore, Mary
    PHARMACOGENETICS AND GENOMICS, 2011, 21 (08): : 506 - 515